Roger Newton

Esperion Therapeutics Reports Financial Details, Corporate UpdateEsperion Therapeutics Inc. (Nasdaq: ESPR), an early-stage pharmaceutical company developing a new class of cholesterol-fighting drugs, Monday provided financial figures and a corporate update.
Tim Mayleben Named President And CEO Of Esperion TherapeuticsEsperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, announced that Tim Mayleben has been named president and CEO of the company.
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen